title: The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment.
authors.forename: John K
authors.initials: JK
authors.lastname: Triantafillidis
authors.forename: Aristofanis
authors.initials: A
authors.lastname: Gikas
authors.forename: Nicolaos
authors.initials: N
authors.lastname: Apostolidiss
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Merikas
authors.forename: Elias
authors.initials: E
authors.lastname: Mallass
authors.forename: George
authors.initials: G
authors.lastname: Peros
mesh_terms: D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016022:Case-Control Studies; D016001:Confidence Intervals; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D016015:Logistic Models; D008297:Male; D016017:Odds Ratio; D015995:Prevalence
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents